Respiratory Motion Correction of Cardiac Combined Positron Emission Tomography and Magnetic Resonance Imaging (PET/MRI)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03200132

Enrollment

Registered

2017-06-27

Start date

2017-06-26

Completion date

2021-10-14

Last updated

2022-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Imaging

Brief summary

This study evaluates the possibility of Magnetic Resonance Imaging (MRI) based respiratory motion correction of simultaneously acquired cardiac Positron Emission Tomography (PET) images.

Interventions

DIAGNOSTIC_TESTCardiac PET/MRI

For patients undergoing 18-Fluor- fluorodeoxyglucose (18F-FDG) PET/MRI or PET/Computed Tomography (CT), additional cardiac PET/MRI scans are acquired.

Study design

Observational model

CASE_ONLY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* 18F-FDG injection for clinical diagnostic PET/MRI or PET/CT

Exclusion criteria

* Diet-suppressed myocardial uptake of 18F-FDG * General

Design outcomes

Primary

Measure	Time frame
Target-to-background ratio (TBR)	15-20 minutes

Secondary

Measure	Time frame
Signal-to-noise ratio (SNR)	15-20 minutes

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026